These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 26402899)

  • 1. [Reaction on 'Psychiatric problems in a motor disorder: psychosis in Huntington's disease'].
    van Duijn E
    Tijdschr Psychiatr; 2015; 57(8):624. PubMed ID: 26402899
    [No Abstract]   [Full Text] [Related]  

  • 2. [Psychiatric problems in a motor disorder: psychosis in Huntington's disease].
    van der Weijde E; Schadé A
    Tijdschr Psychiatr; 2015; 57(3):215-9. PubMed ID: 25856745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Not Available].
    Van Der Weijde E; Schadé A
    Tijdschr Psychiatr; 2015; 57(8):625. PubMed ID: 26437479
    [No Abstract]   [Full Text] [Related]  

  • 4. Olanzapine in the management of psychosis in Huntington’s disease: a case report.
    Huarcaya-Victoria J; Plasencia-Yasuda R; Ñique-Rivas M; Suárez-Agreda K; Cerrato-Huayaney J
    Actas Esp Psiquiatr; 2019 Sep; 47(5):202-8. PubMed ID: 31648344
    [No Abstract]   [Full Text] [Related]  

  • 5. Psychosis with Huntington's disease: role of antipsychotic medications.
    Ding J; Gadit AM
    BMJ Case Rep; 2014 Aug; 2014():. PubMed ID: 25139915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of risperidone in psychosis associated with Huntington's disease.
    Madhusoodanan S; Brenner R
    Am J Geriatr Psychiatry; 1998; 6(4):347-9. PubMed ID: 9793585
    [No Abstract]   [Full Text] [Related]  

  • 7. Quetiapine in the management of psychosis secondary to huntington's disease: a case report.
    Seitz DP; Millson RC
    Can J Psychiatry; 2004 Jun; 49(6):413. PubMed ID: 15283541
    [No Abstract]   [Full Text] [Related]  

  • 8. Aripiprazole effects on psychosis and chorea in a patient with Huntington's disease.
    Lin WC; Chou YH
    Am J Psychiatry; 2008 Sep; 165(9):1207-8. PubMed ID: 18765501
    [No Abstract]   [Full Text] [Related]  

  • 9. Quetiapine in the treatment of behavioral disturbances in patients with Huntington's disease.
    Alpay M; Koroshetz WJ
    Psychosomatics; 2006; 47(1):70-2. PubMed ID: 16384811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The management of psychosis in movement disorder patients.
    Chou KL; Borek LL; Friedman JH
    Expert Opin Pharmacother; 2007 May; 8(7):935-43. PubMed ID: 17472539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aripiprazole treatment for choreoathetoid and psychotic symptoms of Huntington's disease.
    Yavuz KF; Ulusoy S; Alnıak İ
    J Neuropsychiatry Clin Neurosci; 2013; 25(2):E31. PubMed ID: 23686053
    [No Abstract]   [Full Text] [Related]  

  • 12. [Amisulpride in Huntington's disease].
    Saft C; Andrich J; Kraus PH; Przuntek H
    Psychiatr Prax; 2005 Oct; 32(7):363-6. PubMed ID: 16220421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychiatric and neuropsychological abnormalities in Huntington's disease: a case study.
    Madhusoodanan S; Brenner R; Moise D; Sindagi J; Brafman I
    Ann Clin Psychiatry; 1998 Sep; 10(3):117-20. PubMed ID: 9781475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychosis and longitudinal outcomes in Huntington disease: the COHORT Study.
    Connors MH; Teixeira-Pinto A; Loy CT
    J Neurol Neurosurg Psychiatry; 2020 Jan; 91(1):15-20. PubMed ID: 31611263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of psychotic and behavioral symptoms with clozapine, aripiprazole, and reboxetine in a patient with Huntington's disease.
    Edlinger M; Seppi K; Fleischhacker W; Hofer A
    Int Clin Psychopharmacol; 2013 Jul; 28(4):214-6. PubMed ID: 23652781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aripiprazole in the treatment of olanzapine-resistant psychotic and motor symptoms of Huntington's disease.
    Oulis P; Mourikis I; Konstantakopoulos G; Papageorgiou SG; Kouzoupis AV
    J Neuropsychiatry Clin Neurosci; 2010; 22(3):352c.e4-352.e5. PubMed ID: 20686147
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of zuclopenthixol in the treatment of aggression in Huntington's disease.
    Tibrewal P; Bastiampillai T; Dhillon R; Cheng R; Fonseka HT
    Asian J Psychiatr; 2017 Apr; 26():152-153. PubMed ID: 28483083
    [No Abstract]   [Full Text] [Related]  

  • 18. Huntington's disease presenting as a depressive disorder with psychotic features.
    Jardri R; Medjkane F; Cuisset JM; Vallee L; Delion P; Goeb JL
    J Am Acad Child Adolesc Psychiatry; 2007 Mar; 46(3):307-308. PubMed ID: 17314716
    [No Abstract]   [Full Text] [Related]  

  • 19. An overview of psychiatric symptoms in Huntington's disease.
    Anderson KE; Marder KS
    Curr Psychiatry Rep; 2001 Oct; 3(5):379-88. PubMed ID: 11559474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial psychiatric presentation of Huntington's disease.
    Lovestone S; Hodgson S; Sham P; Differ AM; Levy R
    J Med Genet; 1996 Feb; 33(2):128-31. PubMed ID: 8929949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.